Popular Articles

Hydrangea Root Shows Promise In Treating Autoimmune Disorders
US researchers found that a drug made from the root of the hydrangea plant, which has for centuries been used in Chinese medicine, showed
pharmacy online
Officials Hope Health Reform Reaches Rural America
Rural Americans are hopeful that health reform includes funding for clinics and health care services in their communities, where the cost of care is often high, CNN reports.
News of the day
Quintiles Consulting Outlines Methods For Re-Balancing Drug Development Risks
Quintiles Consulting released the first in a three-part series of white papers addressing how best to navigate risk in drug development. The first paper, "On the Re-Balancing of Risk to Transform Cost and Productivity in Drug Development," focuses on operational risk. It is available for download at http://www.quintiles.com/consulting.
Diagnostics

Designer Of The World's First Hand-Held, Non-Contact Vein Illumination Device Meets Stringent ISO 13485 Safety, Design And Distribution Standards

AccuVein LLC, maker of the AV300, the world"s first hand-held, non-contact vein illumination device, announced that its quality system has received an International Organization for Standardization (ISO) 13485 Certification. This certifies to customers around the globe AccuVein"s commitment to the quality and safety of its medical device design, development, production, installation and delivery procedures. The quality system was further designed to meet U.S. FDA Good Manufacturing Practices (cGMP) requirements. AccuVein has begun shipping the AV300 in the U.S. and recently announced agreements with two large group purchasing organizations. In addition the AV300 is available on the General Services Administration Schedule, bringing the AccuVein AV300 to blood centers, hospitals, and government-affiliated institutions across the nation. "AccuVein launched the AV300 to help healthcare professionals locate hard-to-find veins and is committed to ensuring its products are of the highest quality while meeting healthcare provider and patient needs," said Stephen P. Conlon, President of AccuVein. "Receipt of this approval from BSI, an objective and accredited organization, is a critical step forward in our path to deliver the AV300 to healthcare practitioners around the globe." To achieve this three-year certification, AccuVein had to demonstrate that their quality system conforms to the exacting customer and regulatory standards of the ISO. ISO 13485:2003 is specifically designed for regulatory compliance of medical device companies. It supplements ISO 9001 with additional requirements including process control, design control, retention of records, accountability, traceability, and customer satisfaction. AccuVein achieved this key milestone following a careful assessment of their quality management system by BSI Group, a global provider of management systems assessment, certification and training services, with more than 60,000 certified locations and clients in over 100 countries. AccuVein"s quality system meets ISO standard and U.S. FDA Good Manufacturing Practices requirements. For a copy of AccuVein"s ISO 13485:2003 certificate, please visit http://www.AccuVein.com/quality. AccuVein


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):